-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tl9z/aDbdIDGMDmeiAzm2RugVQdpjxofFACc8jvIXH5/dLaqoAXfc3GNtYn1JvCe PuHvaI1mHOpAjcOfdXtx4g== 0001169232-06-000387.txt : 20060202 0001169232-06-000387.hdr.sgml : 20060202 20060202115705 ACCESSION NUMBER: 0001169232-06-000387 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041124 FILED AS OF DATE: 20060202 DATE AS OF CHANGE: 20060202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN PHARMA GLOBAL INC CENTRAL INDEX KEY: 0001197088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 06572321 BUSINESS ADDRESS: STREET 1: SPARC AKOTA ROAD CITY: VADODARA STATE: A1 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHANGHVI DILIP S CENTRAL INDEX KEY: 0001249644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 06572320 BUSINESS ADDRESS: STREET 1: 1150 ELIJAH MCCOY CITY: DETROIT STATE: MI ZIP: 48202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0001197089 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 06572322 BUSINESS ADDRESS: STREET 1: SPARC AKOTA ROAD CITY: VADODARA STATE: K7 ZIP: 390020 BUSINESS PHONE: 01191228212128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CARACO PHARMACEUTICAL LABORATORIES LTD CENTRAL INDEX KEY: 0000887708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382505723 STATE OF INCORPORATION: MI FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1150 ELIJAH MCCOY DR CITY: DETROIT STATE: MI ZIP: 48202 BUSINESS PHONE: 3138718400 MAIL ADDRESS: STREET 1: 1150 ELIJAH MCCOY DRIVE CITY: DETROIT STATE: MI ZIP: 48202 4 1 d06-66606_ex.xml X0202 4 2004-11-24 0 0000887708 CARACO PHARMACEUTICAL LABORATORIES LTD CPD 0001197089 SUN PHARMACEUTICAL INDUSTRIES LTD SPARC, TANDALJA VADODARA, GUJARAT K7 309 020 INDIA 0 0 1 0 0001197088 SUN PHARMA GLOBAL INC 0 0 1 0 0001249644 SHANGHVI DILIP S 1 1 1 0 Chairman of the Board Common Stock 8382666 D Common Stock 8486014 I See Footnote Series B. Preferred Stock 0 2004-11-24 4 J 0 544000 A 2007-11-24 Common Stock 544000 3808000 I See Footnote Series B. Preferred Stock 0 2004-12-06 4 J 0 544000 A 2007-12-06 Common Stock 544000 4352000 I See Footnote Series B. Preferred Stock 0 2005-01-25 4 J 0 544000 A 2008-01-25 Common Stock 544000 4896000 I See Footnote Series B. Preferred Stock 0 2005-03-05 4 J 0 544000 A 2008-03-05 Common Stock 544000 5444000 I See Footnote Series B. Preferred Stock 0 2005-03-22 4 J 0 544000 A 2008-03-22 Common Stock 544000 5984000 I See Footnote Series B. Preferred Stock 0 2005-05-02 4 J 0 544000 A 2008-05-02 Common Stock 544000 6528000 I See Footnote Series B. Preferred Stock 0 2005-07-11 4 J 0 544000 A 2008-07-11 Common Stock 544000 7072000 I See Footnote Series B. Preferred Stock 0 2005-07-14 4 J 0 544000 A 2008-07-14 Common Stock 544000 7616000 I See Footnote Series B. Preferred Stock 0 2005-08-25 4 J 0 544000 A 2008-08-25 Common Stock 544000 8160000 I See Footnote Series B. Preferred Stock 0 2005-10-27 4 J 0 544000 A 2008-10-27 Common Stock 544000 8704000 I See Footnote Series B. Preferred Stock 0 2005-12-31 4 J 0 544000 A 2008-12-31 Common Stock 544000 9248000 I See Footnote Series B. Preferred Stock 0 2006-01-12 4 J 0 544000 A 2009-01-12 Common Stock 544000 9792000 I See Footnote On January 25, 2005, Sun Pharmaceutical Industries Limited ("Sun") transferred 5,131,317 shares of Common Stock to its wholly-owned subsidiary, Sun Pharma Global, Inc. ("Sun Global"). These shares are owned directly by Sun. Dilip S. Shanghvi is the controlling shareholder of Sun. These shares are owned directly by Sun Global, which is a wholly-owned subsidiary of Sun. Dilip S. Shanghvi is the controlling shareholder of Sun. The Series B preferred shares are convertible into common stock after three years (or immediately upon a change in control) on a one-to-one basis. Sun Global earns 544,000 shares of Series B Preferred Stock for each technology transfer to Caraco of a generic drug by Sun Global when such drug passes its bioequivalency studies. In the event of the dissolution of Caraco, such shares have a preference equal to the value attributed to them on the dates on which they were earned as follows: 11-24-04 ($5.50 per share); 12-06-04 ($5.93 per share); 1-25-05 ($6.65 per share); 3-05-05 ($6.32 per share); 3-22-05 ($5.78 per share); 5-2-05 ($5.96 per share); 7-11-08 ($6.37 per share); 7-14-05 ($6.61 per share); 8-25-05 ($6.63 per share); 10-27-05 ($6.38 per share); 12-31-05 ($6.74 per share); and 1-12-06 ($7.38 per share). The shares of Series B Preferred Stock remain outstanding until such time as they are converted into Common Stock. /s/ Sudhir V. Valia, Director 2006-01-23 /s/ Sudhir V. Valia, Director 2006-01-23 /s/ Dilip S. Shanghi 2006-01-23 -----END PRIVACY-ENHANCED MESSAGE-----